Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
603168.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
+214%
0
vs -0.00
Q1.23
-33%
0.06
vs 0.09
Q2.23
+425%
0.14
vs 0.03
Q3.23
-49%
0.02
vs 0.03
Q4.23
N/A
-0.17
vs 0
Q1.24
-83%
0.01
vs 0.06
Q2.24
N/A
-0.07
vs 0.14
Q3.24
N/A
-0.02
vs 0.02
Q4.24
N/A
-0.23
vs -0.17
Q1.25
+100%
0.02
vs 0.01
Sales Growth
YoY
Current
Estimates
Q4.22
-14%
135.1M vs 156.7M
Q1.23
+9%
162.2M vs 149.4M
Q2.23
+37%
179.4M vs 130.7M
Q3.23
+17%
157.2M vs 134.3M
Q4.23
+8%
146.2M vs 135.1M
Q1.24
-15%
137.8M vs 162.2M
Q2.24
-45%
99M vs 179.4M
Q3.24
-22%
122.5M vs 157.2M
Q4.24
-15%
124.6M vs 146.2M
Q1.25
-26%
101.7M vs 137.8M
Return on Equity
QoQ
Q2.23
+3%
0.03
vs 0.01
Q3.23
+0%
0
vs 0.03
Q4.23
-3%
-0.03
vs 0
Q1.24
+0%
0
vs -0.03
Q2.24
-2%
-0.02
vs 0
Q3.24
0%
-0.00
vs -0.02
Q4.24
-6%
-0.06
vs -0.00
Q1.25
+1%
0.01
vs -0.06
Institutionnal Ownership
Relative Strength
603168.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antipyretic and analgesic, antibacterial anti-inflammatory, endocrine, auxiliary, cardiovascular, detoxification, diuretic row stone, gynecology, and infusion categories. It offers its products in injections, oral solutions, eye drops, tablets, capsules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China.
SHH
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.01Â ( -0.13%)
Relative Strenght
Volume Buzz
-30%
Earning Acce
No
Dist 52w H.
19%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 603168.SS compares to sector?